Gentamicin and norfloxacin prophylaxis for transrectal ultrasound-guided prostate biopsy
Healthcare Infection,  Clinical Article

Jeremiah CJ et al. – Transrectal ultrasound guided prostate biopsy (TRUSPB) is the mainstay of diagnosis for prostate cancer. Clinical trials have established that antibiotic prophylaxis is effective in reducing infective complications, but breakthrough bacteraemia has been described with multiresistant organisms. The authors reviewed the rate of bacteraemia and re–admission in patients undergoing TRUSPB. Recent reports of breakthrough bacteraemia suggest that effectiveness of single agent fluoroquinolone or gentamicin prophylaxis may be compromised by increasing rates of resistance. Combination prophylaxis with gentamicin and norfloxacin is associated with a low rate of infective complications.


  • The Alfred Hospital is a tertiary referral hospital in Melbourne, Australia.
  • The routine antibiotic prophylactic regimen is gentamicin and norfloxacin.
  • Patients undergoing TRUSPB at the Alfred Hospital were linked to databases of blood and urine cultures, and to admissions with infective complications within 14 days.


  • Between June 2007 and July 2010, 459 patients underwent TRUSPB at the Alfred Hospital.
  • No patient (95% CI: 0, 0.8%) had a positive blood culture, and one patient had a positive urine culture (95% CI: 0.04, 1.2%) within 14 days of the procedure.
  • There were two readmissions: a 66 year old man with systemic culture–negative sepsis, and a 54 year old man with a urinary tract infection.
  • In 50 randomly selected patients, all patients received norfloxacin but only 80% of patients received gentamicin.
  • Between 2007 and 2010, 6.0% of isolates were non–susceptible to norfloxacin, 5.8% were non–susceptible to gentamicin and 3.2% were non–susceptible to both gentamicin and norfloxacin.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Urology

See All >> Messages include industry-sponsored communications and special communications from MDLinx


Most Popular Urology Articles

1 Who dies from prostate cancer? Prostate Cancer & Prostatic Diseases, October 17, 2014    Clinical Article

2 Metformin use and prostate cancer risk Full Text European Urology, December 9, 2014    Free full text    Clinical Article

3 Boiled coffee consumption and the risk of prostate cancer: follow-up of 224,234 Norwegian men 20-69 years British Journal of Cancer, December 24, 2014    Clinical Article

4 Male pattern baldness in relation to prostate cancer risks: An analysis in the Vitamins and lifestyle (VITAL) cohort study The Prostate, December 12, 2014    Clinical Article

5 The use of aspirin and the risk of mortality in patients with prostate cancer The Journal of Urology, December 8, 2014    Clinical Article

6 Impact of the U.S. preventive services task force recommendations against PSA screening on prostate biopsy and cancer detection rates The Journal of Urology, December 10, 2014    Clinical Article

7 Metformin use and prostate cancer risk Full Text European Urology, November 19, 2014    Free full text    Clinical Article

8 Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: Analysis of 495,321 participants International Journal of Clinical Practice, December 16, 2014    Clinical Article

9 Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia Urology, December 15, 2014    Clinical Article

10 Time to onset of clinically meaningful improvement with tadalafil 5mg once daily in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: analysis of data pooled from four pivotal, double-blind, placebo-controlled studies The Journal of Urology, December 1, 2014    Clinical Article

11 Castration-resistant prostate cancer: AUA guideline amendment The Journal of Urology, November 21, 2014    Clinical Guideline

12 Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: A meta-analysis Journal of Cancer Research and Therapeutics, December 9, 2014    Clinical Article

13 Standards for prostate biopsy Current Opinion in Urology, February 18, 2014    Clinical Article

14 Calcium and phosphorus intake and prostate cancer risk: A 24-y follow-up study American Journal of Clinical Nutrition, November 26, 2014    Clinical Article

15 Diethylstilboestrol (1 mg) in the management of castration-resistant prostate cancer Urologia Internationalis, October 21, 2014    Clinical Article

16 A systematic literature review of life expectancy prediction tools for localized prostate cancer patients The Journal of Urology, December 2, 2014    Clinical Article

17 A genetic-based approach to personalized prostate cancer screening and treatment Current Opinion in Urology, December 17, 2014    Clinical Article

18 A meta-analysis of coffee intake and risk of urolithiasis Urologia Internationalis, February 7, 2014    Clinical Article

19 Physical activity and survival among men diagnosed with prostate cancer Cancer Epidemiology, Biomarkers & Prevention, December 22, 2014    Clinical Article

20 Coffee consumption and prostate cancer risk: An updated meta-analysis Cancer Causes and Control, March 3, 2014    Evidence Based Medicine    Clinical Article

Indexed Journals in Urology: Urology, Journal of Urology, European Urology, The Prostatemore

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List